Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine volume in carpal tunnel release
NCT03729375Phase 1Completed
- Sponsor
- University of South Florida
- Start
- Oct 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine in carpal tunnel syndrome (CTS) (2 arms), sponsored by University of South Florida. Primary endpoint: Change in Pain Level at 2 weeks. Started Oct 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT03729375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03729375.